MerTK blockade increases tumor immunogenicity and potentiates antitumor immunity via the transfer of tumor-derived cGAMP into TAMs through the ATP-gated channel P2X7R and subsequent STING activation47. The gene discussed is MERTK; the disease is neoplasm.